← Leaderboards
Edwin M Stone
University Of Iowa
$8,505,416
Attributed
$12,569,856
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,569,856 · 7
By mechanism
R01$12,569,856 · 7
Top collaborators
- Budd A Tucker15 shared
- Robert Foster Mullins9 shared
- David M Gamm4 shared
- Kimerly Ann Powell1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Budd A Tucker$8,644,636
- Robert Foster Mullins$9,156,220
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMutationBlindnessCellsInduced Pluripotent Stem CellPhotoreceptorsPhenotypeAffectTissuesVariantFunctional DisorderAge Related Macular DegenerationCessation Of LifeRetinaAllelesMolecularGenome EditingGeneticDegenerative DisorderInheritedNeural RetinaCohortClustered Regularly Interspaced Short Palindromic RepeatsEffective Therapy
Grant awards (29)
Non-destructive assessment of retinal differentiation capacity and developmental maturity$618,600
R01 · FY2025 · EY
A Next Generation Outer Retinal Microphysiological System$386,250
R01 · FY2025 · EY
A Next Generation Outer Retinal Microphysiological System$386,250
R01 · FY2024 · EY
A Next Generation Outer Retinal Microphysiological System$386,250
R01 · FY2023 · EY
A Next Generation Outer Retinal Microphysiological System$386,250
R01 · FY2022 · EY
CRISPR-Cas9 based treatment of dominant retinal degeneration$374,300
R01 · FY2022 · EY · contact PI
CRISPR-Cas9 based treatment of dominant retinal degeneration$378,902
R01 · FY2021 · EY · contact PI
CRISPR-Cas9 based treatment of dominant retinal degeneration$394,890
R01 · FY2020 · EY · contact PI
Unraveling the 10q AMD Risk Locus$495,753
R01 · FY2019 · EY · contact PI
Unraveling the 10q AMD Risk Locus$495,753
R01 · FY2018 · EY · contact PI
Disease Mechanisms in Best Disease$491,519
R01 · FY2018 · EY · contact PI
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerations$343,125
R01 · FY2018 · EY · contact PI
Unraveling the 10q AMD Risk Locus$495,753
R01 · FY2017 · EY · contact PI
Disease Mechanisms in Best Disease$491,519
R01 · FY2017 · EY · contact PI
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerations$343,125
R01 · FY2017 · EY · contact PI
Unraveling the 10q AMD Risk Locus$495,753
R01 · FY2016 · EY · contact PI
Disease Mechanisms in Best Disease$491,519
R01 · FY2016 · EY · contact PI
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerations$342,282
R01 · FY2016 · EY · contact PI
Disease Mechanisms in Best Disease$501,681
R01 · FY2015 · EY · contact PI
Molecular Genetics of Age Related Macular Degeneration$529,575
R01 · FY2013 · EY · contact PI
Molecular Genetics of Age Related Macular Degeneration$557,447
R01 · FY2012 · EY · contact PI
Molecular Genetics of Age Related Macular Degeneration$557,139
R01 · FY2011 · EY · contact PI
Molecular Genetics of Age Related Macular Degeneration$422,858
R01 · FY2010 · EY · contact PI
Fibulin-Associated Age-Related Macular Degeneration$374,645
R01 · FY2009 · EY · contact PI
Fibulin-Associated Age-Related Macular Degeneration$360,182
R01 · FY2008 · EY · contact PI
Fibulin-Associated Age-Related Macular Degeneration$368,028
R01 · FY2007 · EY · contact PI
Fibulin-Associated Age-Related Macular Degeneration$361,365
R01 · FY2006 · EY · contact PI
Fibulin-Associated Age-Related Macular Degeneration$423,425
R01 · FY2005 · EY
MOLECULAR GENETICS OF CORNEAL DYSTROPHIES$315,718
R01 · FY2000 · EY